Halozyme Therapeutics, Inc. (HALO)

70.43 -0.78 (-1.10%) USD  |  NASDAQ  |  Jan 20, 16:00
70.25 -0.18 (-0.26%) Pre-Market: 08:25
More

Halozyme Therapeutics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade